Cancer NGS Jour Fixe - Thema: "FLT3-ITD Based Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia (AML)"

Dear Colleagues
 
We would like to invite you to the next CANCER NGS JOUR FIXE. 

• Date:  8th November, 2018
• Time/Venue:  08:30 a. m./ CCCC, Invalidenstr. 80, Teleconference room, Level 2
• Speaker:  Tamara Blätte, Charité–Universitätsmedizin, Klinik für Innere Medizin mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, CVK
• Title:  "FLT3-ITD based  measurable residual disease (MRD) monitoring in Acute Myeloid Leukemia (AML)"
   

The upcoming cancer NGS meetings are scheduled as follows. SAVE THE DATES!
 
>> 06.12.2018/Soulafa Mamlouk, Charité–Universitätsmedizin, Institute of Pathology, Laboratory of Molecular Tumor Pathology
 
In the framework of the Cancer NGS Jour Fixe presentations of your recent work or suggestions for topics are always welcome. Please contact us.
 
We look very much forward to an interesting exchange of thoughts and experiences as well as to exciting discussions. All are most warmly invited to attend.
 
Kind regards 
 
Christine Sers     Ingeborg Tinhofer
 
p.p. Doreen Ditzen

Kontakt